ENNasopharyngeal cancer treatment in Germany rests on radiotherapy; the surgeon steps in only in particular situations. A patient handed the words «nasopharyngeal carcinoma» usually looks for a surgeon first, yet this is the one head and neck tumour where that search leads the wrong way.
Below: how the diagnosis is confirmed in Germany, what the plan is built from, what will be hard and what is checked for years afterwards. For the wider picture, see cancer treatment in Germany.
What nasopharyngeal cancer is and why it is found late
Nasopharyngeal cancer is a malignant tumour of the uppermost throat, usually found late because of where it grows: behind the nose, above the soft palate, deep enough that nobody looks in there without an endoscope.
A painless swollen node in the neck is most often the first sign. Then come a nose blocked on one side, blood-streaked mucus, a blocked feeling and hearing loss in one ear from fluid in the middle ear, headache and, in advanced disease, double vision and facial numbness on one side.
One fact deserves an honest sentence: this tumour is spread unevenly. It is markedly more common in southern China, Southeast Asia, North Africa and the Gulf states than in central Europe, as the maps of the WHO cancer agency IARC show, and most cases are linked to the Epstein-Barr virus.
What has to be done before a plan can be named
First comes endoscopy of the nasopharynx with a biopsy: nothing moves forward without histology. The neck is examined at the same appointment, and a suspicious node is sampled too, with a needle.
MRI of the skull base and neck is the key scan: it shows whether the tumour has reached the skull base and neighbouring structures. CT is added for bone, and PET-CT to look for distant deposits and assess the nodes; see PET-CT in Germany.
Some steps before radiotherapy surprise patients: hearing is tested, a dentist sees the patient because teeth inside the radiation field are treated in advance, and someone assesses whether the patient will be able to eat during the course. Epstein-Barr virus DNA in plasma is measured as a supporting marker of prognosis and course; it does not replace the biopsy.
Why a radiation oncologist leads the treatment, not a surgeon
Anatomy decides it: the nasopharynx lies right against the skull base, large vessels and nerves, so removing the tumour with a margin of healthy tissue is barely possible there, while the tumour responds well to radiation.
The method is intensity-modulated radiotherapy (IMRT), which shapes the dose around the brainstem, the optic pathway and the salivary glands. The course takes several weeks of daily sessions; the clinic names the exact number of sessions and the dose in a written plan.
Proton therapy is discussed when the tumour sits close to the brainstem or the optic pathway and the dose on them should drop further; the tumour board decides, not a patient reading advertising (see proton therapy in Germany). The surgeon removes residual or returning neck nodes and, in selected recurrences, operates endoscopically in the nasopharynx. Among AlenMed’s partners this is done by the Head and Neck Clinic of the Agaplesion Frankfurter Diakonie Kliniken, whose chief physician PD Dr Balazs B. Lörincz specialises in oncological and reconstructive head and neck surgery and in robot-assisted operations.
When chemotherapy and immunotherapy are added
Chemotherapy is added in locally advanced disease; immunotherapy is discussed when the disease returns or has spread. In the first case radiotherapy is combined with platinum-based chemotherapy, and some protocols open with induction chemotherapy. The aim is not a bigger dose but a tumour more sensitive to radiation; see chemotherapy in Germany.
Drugs that block immune checkpoints such as PD-1 are discussed when the disease returns or has spread, not as first-line treatment of a newly found local tumour. A sober note: no result can be promised, and talk of a «cure rate» without the stage and the histology in hand is meaningless.
Side effects, recovery and follow-up
The hardest time is the height of the course, and follow-up runs for years. In those weeks the lining of the mouth and throat is inflamed, the mouth is dry because radiation reaches the salivary glands, taste changes and swallowing hurts; how the patient will get food and fluid is agreed in advance, and swallowing and speech therapists are involved.
Follow-up is long because late effects of radiation appear slowly: after radiation to the neck, thyroid function and hearing are checked, pituitary hormones are watched and the nasopharynx is examined endoscopically on a schedule. Who runs this follow-up at home, and at what intervals, goes into the final report.
Frequently asked questions
Is surgery needed for nasopharyngeal cancer?
As the main treatment, usually not. A newly found tumour is irradiated, in locally advanced disease together with platinum-based chemotherapy. Surgery comes in when neck nodes remain after the course or the disease returns: the nodes are removed, and in selected cases the nasopharynx is operated on endoscopically.
How long does nasopharyngeal cancer treatment in Germany take?
Radiotherapy alone takes several weeks of daily sessions; if the plan opens with induction chemotherapy, the treatment takes longer. The clinic’s written plan gives the exact number of sessions, and it decides how long the visa, the accommodation and the companion’s stay must cover.
Can follow-up after radiotherapy take place at home?
Yes. After the course the patient goes home and local doctors take over. The German clinic’s final report therefore states what to check, namely thyroid and pituitary function, hearing and the nasopharynx at endoscopy, and at what intervals; have it translated for your doctors before you leave.
How AlenMed arranges nasopharyngeal cancer treatment in Germany
AlenMed starts with the documents: histology, MRI and CT discs and discharge letters go to the clinic, and the tumour board answers which examinations must be repeated and what the plan will be. Then come a written estimate, a visa invitation and an interpreter at appointments and when the plan is discussed. If the diagnosis was made at home and it is the plan that looks questionable, a second opinion from a German doctor makes more sense than flying in for a course of treatment.
Plan for everyday life too: radiotherapy means several weeks on the spot, accommodation near the clinic, a companion, help with eating on the worst days and a translation of the final report for the doctors at home.
This material is for information only and is not an offer; a doctor decides the treatment plan at an in-person consultation.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
